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Laser surgery of early glottic cancer in elderly
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
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SUMMARY
Aim of this retrospective study is to evaluate the impact of transoral laser surgery of early glottic cancer in elderly patients in terms of 
feasibility, disease-free survival, overall survival and organ preservation, in a single Institute (European Institute of Oncology). A total of 
122 patients (male/female ratio 113/9), over 70s with untreated early stage glottic cancer, were consecutively evaluated and treated at the 
European Institute of Oncology from 2000 to 2008. None had contraindications to general anaesthesia and all patients signed informed 
consent to this surgical treatment. The severity of pre-operative comorbidities and the intra-operative risk were evaluated according to 
the American Society of Anaesthesiologists Grading Classi cation. All patients underwent laser cordectomies according to the European 
Laryngological Society classi cation. Histopathological examination demonstrated no evidence of tumour (pT0) in 19 patients (calculated 
only in patients with a previous vocal cord biopsy positive for squamous cell carcinoma), pTis in 18, pT1a in 53, pT1b in 16, pT2 in 14 and 
pT3 in 2, respectively. A 10-year overall survival, a tumour speci c survival and a laryngeal tumour-speci c survival were, respectively, 
64.9%, 84.8% and 94.3%. In conclusion, transoral laser surgery is feasible in elderly patients with early stage glottic cancer, providing 
good results in terms of disease-free survival, organ preservation and quality of life. Our group of elderly patients had no intra-operative or 
post-surgical complications and resumed normal activities the day after discharge from hospital. Considering these factors, we can assess, 
that transoral laser surgery, therefore, represents a modern treatment that should be offered as an alternative to conventional radiotherapy in 
elderly patients with early glottic cancer referred to medical centres with expertise for this surgical procedure.
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RIASSUNTO
Questo studio retrospettivo si propone di valutare l’impatto della chirurgia transorale nelle neoplasie glottiche in stadio iniziale nei 
pazienti anziani trattati in un singolo Centro (Istituto Europeo di Oncologia) in termini di fattibilità, sopravvivenza libera da malattia, 
sopravvivenza globale. Sono stati valutati 122 pazienti consecutivi (rapporto maschi/femmine 113/9), con età superiore od uguale ai 70 
anni con neoplasia glottica non precedentemente trattata, senza controindicazioni all’anestesia generale, trattati presso l’Istituto Europeo 
di Oncologia dal 2000 al 2008. Tutti hanno  rmato il consenso informato all’intervento endoscopico. La valutazione preoperatoria della 
gravità delle comorbidità e del rischio intra-operatorio, è stata valutata mediante la Classi cazione della Società Americana di Anestesio-
logia (ASA). Gli interventi di cordectomia endoscopica sono stati eseguiti secondo la classi cazione dell’European Laryngological Society. 
L’esame istopatologico de nitivo non ha dimostrato evidenza di tumore (pT0) in 19 pazienti (dato calcolato solo nei casi precedentemente 
sottoposti a biopsia incisionale positiva per carcinoma a cellule squamose), pTis in 18 pazienti, pT1a in 53, pT1b in 16, pT2 in 14 e pT3 
in 2 casi. La sopravvivenza globale a 10 anni, la sopravvivenza tumore speci ca e quella tumore-laringeo speci ca sono rispettivamente 
del 64,9%, 84,8 e 94,3%. In conclusione la chirurgia transorale endoscopica della laringe è proponibile nei pazienti anziani con tumore 
glottico in stadio iniziale, con buoni risultati, in termini di sopravvivenza libera da malattia, di preservazione d’organo e di qualità di 
vita. Il nostro gruppo di pazienti anziani non ha avuto complicanze intra- o post-operatorie e tutti hanno ripreso le loro normali attività 
il giorno dopo la dimissione dall’ospedale. Considerando questi fattori possiamo asserire che la chirurgia transorale dovrebbe essere il 
trattamento di scelta per le neoplasie glottiche in stadio iniziale anche nel paziente anziano, laddove esista l’attrezzatura e l’esperienza 
adeguata con questa metodica.
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Introduction
Early glottic cancer (Tis, T1a, T1b, T2) is one of the 
most curable malignancies in the head and neck, because 
not only the symptom of hoarseness allows an early di-
agnosis, but also, as a result of the glottis peculiar lym-
phatic drainage less than 1% of patients develop cervical 
metastasis. Laryngeal carcinoma makes up less than two 
percent of cancers worldwide, even though the incidence 
is increasing. In Italy and the rest of Europe, the popula-
tions are becoming older, and with ageing, the prevalence 
of cancer also increases: the skin and the aero-digestive M. Ansarin, et al.
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tract  are  the  predominant  cancers  encountered  in  the 
elderly, and laryngeal squamous cell carcinoma must be 
expected to increase in the future 1 2. Until recently, the 
borderline between middle and old age was 65 years 3; 
the National Institute on Aging and the National Institute 
of Health have rede ned the term “elderly”, placing it 
into three subcategories: “young old” for patients aged 
between 65 and 74 years, “older old” for patients aged 
between 75 and 85 years and “oldest old” for patients 
aged more than 85 years old 4. Because elderly patients 
are characterized by age-speci c problems, Socinski et 
al., offered a different de nition: “old is when his health 
status  begins  to  interfere  with  oncological  decision-
making guidelines” 5. For these reasons, chronological 
age by itself cannot be considered the only criterion for 
the treatment planning decision: particularly nowadays, 
a Comprehensive Geriatric Assessment is highly recom-
mended in geriatric oncology.
Today, external beam radiotherapy and transoral laser sur-
gery (TLS) with CO2 laser are the most common treatment 
modalities for early glottic cancer 6. Radiotherapy is the 
most applied therapy worldwide, but since the early 1970s 
the advent of the CO2 laser made transoral excision more 
and more popular. Several studies also suggested how open 
partial  laryngectomies,  such  as  supra-cricoid  or  fronto-
lateral partial laryngectomy, can be employed as primary 
treatment modalities for early-intermediate-stage larynge-
al cancer in elderly patients 7. However, there is common 
consent that, in elderly patients, open partial laryngectomy 
should not be proposed as the  rst treatment option.
The principal aim of both radiation and surgical oncology 
is cancer cure, but before deciding the treatment schedule, 
it is important to know not only the patient’s wishes but 
also his life expectancy.
The aim of this study is to assess the impact of TLS in 
early-stage glottic cancer in terms of feasibility, disease-
free survival, overall survival, organ preservation and cost 
bene t in elderly patients.
Materials and methods
Between January 2000 and May 2008, 122 patients (male/
female ratio 113/9; mean age, 74 years; age range 70-88 
years) with early stage glottic cancer were treated at the 
Head and Neck Division at the European Institute of On-
cology in Milan, Italy.
Many patients had different co-morbidities such as high 
blood pressure, coronary artery disease, chronic obstruc-
tive pulmonary disease, kidney disorders and others, pre-
senting alone or in combination (Table I).
According to the American Society of Anaesthesiologists 
(ASA) score 8, we divided our group of patients into four 
subgroups (Table I). Many patients were classi ed as ASA 2 
(patient with mild systemic disease, 57 pts, 46.7%) or ASA 
3 (patient with severe systemic disease, 50 pts, 41.0%).
Patients treated between 2000 and 2002, were reclassi-
 ed according to the latest UICC classi cation 9. Clinical 
evaluations and pathological results are summarised in 
Table I. Only two patients underwent radiotherapy before 
laryngeal laser surgery.
The proposed therapeutic protocol (transoral laser cordec-
tomy) was discussed with the patient including risks, ben-
e ts and alternatives to the proposed treatments. Written 
informed consent was obtained in accordance with hospi-
tal protocols as described in our previous publication 10.
All operations were performed under general anaesthe-
sia  with  oro-tracheal  intubation  using  a  laser-safe  en-
dotracheal tube (Laser Flex Tracheal tube, Mallinckrodt, 
USA). For the laser treatment, a 25 Watt Martin CO2 Laser 
(Martin, Germany) with a beam spot of 150 microns was 
Table I. Patient and tumour characteristics of patients treated with eTLS 
(n = 122 patients).
Characteristics N (%)
Age (Years)
   Median (range) 74 (70-88)
Sex
   Males 113 (92.6)
   Females 9 (7.4)
Co-morbidity
   None 1 (0.8)
   Hypertension 23 (18.8)
   Heart disease 18 (14.7)
   COPD 5 (4.1)
   Kidney 1 (0.8)
   More than one 45 (36.9)
   Other 29 (23.8)
ASA score
   1 11 (9.0)
   2 57 (46.7)
   3 50 (41.0)
   4 4 (3.3)
Clinical Stage (for glottic cancer)
   T in situ 9 (7.4)
   T1a 103 (84.4)
   T1b 2 (1.6)
   T2 8 (6.6)
Pathological Stage (for glottic cancer)
   T in situ 18 (14.7)
   T0 19 (15.6)
   T1a 53 (43.4)
   T1b 16 (13.1)
   T2 14 (11.5)
   T3 2 (1.6)Laser surgery of early glottic cancer in elderly
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used. The parameters used were as follows: super-pulse 
continual mode with an output beam power set to 0.8-4.7 
Watt. The cordectomies were classi ed by the European 
Laryngological Society Classi cation 11.
Surgical techniques used in these series of patients were 
described  in  our  previous  publication  10.  The  different 
types of cordectomies are summarized in Table II.
In all cases, including enlarged cordectomies (type III-V), 
specimen resections were carried out with an “en bloc” 
technique. In no cases was an intra-operative biopsy was 
performed.
In  close  collaboration  with  the  same  pathologist,  the 
pathological specimen was oriented and whole-mounted 
on a sponge support to prevent tissue retraction before 
being  xed in buffered 10% formalin. Before the speci-
mens were  xed, every margin was stained with ink and 
oriented. The specimen was then serially-sectioned into 5 
micron-thin sections and stained with haematoxylin and 
eosin and assessed for histological diagnosis. All resec-
tion margins were evaluated and the distance between tu-
mour and specimen margins was measured.
Results
Between January 2000 and May 2008 more than 460 TLS 
for early glottic cancer were performed in our Division. 
One hundred and twenty-two (26.5%) patients resulted to 
be over 70 years of age.
De nitive  histopathological  examination  of  the  surgi-
cal specimens for the entire elderly patient cohort dem-
onstrated  no  evidence  of  tumour  (pT0)  in  19  patients 
(15.6%) (calculated only in patients with a previous vocal 
cord biopsy positive for squamous cell carcinoma), pTis 
in 18 patients (14.7%), pT1a in 53 patients (43.4%), pT1b 
in 16 cases (13.1%), pT2 in 14 cases (11.5%) and pT3 due 
to invasion of the paraglottic space in 2 patients (1.6%).
The disease-free margins were obtained in 88/122 patients 
(72.1%). Close margins were observed in 13 patients (10.7%), 
while one or more than one positive resection margin were 
found in 12 (9.8%) and 8 (6.6%) patients respectively.
In the 88/122 patients with disease-free margins, no fur-
ther treatment was performed. Ten (11%) patients experi-
enced a local recurrence. Nine of them were retreated with 
TLS and one with total laryngectomy. Only one patient in 
this group died from the laryngeal disease.
In the 33/122 patients with close-to-positive margins, 
18/33  received  a  second  transoral  laser  surgery,  4/33 
received post-operative RT, 3/33 a second transoral la-
ser surgery plus adjuvant RT and no further treatment 
in 8/33.
Regarding costs/bene ts, we analyzed the duration of the 
treatment (cordectomies under general anaesthesia), glo-
bal recovery and post surgery recovery time in the hos-
pital. The median time of the surgical treatment, consid-
ering all different types of cordectomies and calculated 
from the induction of the anaesthesia to the removal of 
the anaesthesiology tube, was approximately 112 minutes 
(range 60-243 minutes). The median total recovery time 
was 3 days (range 1-11 days) and the median post-surgical 
recovery time was 2 days (range 0-8) (Table II).
We had no complications relating either to the anaesthe-
siological or surgical procedures. No patient needed a tra-
cheotomy or feeding tube.
With  a  median  follow-up  of  57  months  (range  5-116 
Table II. Patient and tumour characteristics after excision (n = 122 
patients).
Characteristics N (%)
Type of Cordectomy
   I 8 (6.6)
   II 42 (34.4)
   III 46 (37.7)
   IV 6 (4.9)
   V 20 (16.4)
Histology
   SCC 86 (71.1)
   LIN 1-3 27 (22.3)
   Paracheratosis 9 (6.6)
Margins
   Negatives 88 (72.1)
   1 inﬁltrated margin 12 (9.8)
   > 1 inﬁltrated margin 8 (6.6)
   Close 13 (10.7)
   Not evaluable 1 (0.8)
Post-cordectomy Anterior Commissure Involvement
   No 108 (88.5)
   Yes 14 (11.5)
Grading
   0 42 (34.7)
   1 18 (14.9)
   2 54 (44.6)
   3 7 (5.8)
Radicalization
   No 102 (83.6)
   Yes (outcome = SCC) 3 (2.5)
   Yes (outcome = LIN 1-3) 3 (2.5)
   Yes (outcome = granulation) 14 (11.4)
Duration of surgery (min)
   Median (range) 112 (60-243)
Total hospital stay (days)
   Median (range) 3 (1-11)
Post-surgery stay (days)
   Median (range) 2 (0-8)M. Ansarin, et al.
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months, latest census October 2008), 99 patients (81.1%) 
are alive without disease; one patient (0.8%) is alive with 
local disease, while 18 patients (14.7%) died from other 
causes without evidence of loco-regional disease and 4 
patients (3.3%) died from the laryngeal cancer.
In 11/122 (9%) patients, we observed a second primary 
tumour during the follow-up period: 9/11 patients were 
treated for the second primary cancer and resulted to be 
alive at last follow-up, while 2/11 died from the second 
tumour (in both cases lung cancer) (Table III).
We achieved a 10-year overall survival, a tumour speci c 
survival and a laryngeal tumour-speci c survival respec-
tively of 64.9%, 84.8 and 94.3% (Fig. 1 and Table IV).
Relapse  occurred  in  19/122  (15.5%)  patients.  Relapse 
was local in 17 cases and regional in 2 cases, which were 
treated with the following modalities:
r FOEPTDPQJDSFTFDUJPOXJUIMBTFSJODBTFT	

and laser plus RT in 4/19 (21.05%);
r FYDMVTJWF35JODBTF	

r FYDMVTJWF$5JODBTF	

r UPUBMMBSZOHFDUPNZJODBTFT	POFQMVTBEKVWBOU
RT) (21.05%);
r TFMFDUJWFOFDLEJTTFDUJPOBOE35JODBTFT	

At the time of follow-up, 12/19 patients were free of dis-
ease, 3/19 had died from other causes, 1/21 was alive with 
disease and 3/19 were dead with disease.
Fig. 1. Cumulative incidence for 10-years mortality.
Table III. Follow-up data (n = 122 patients).
Characteristics N (%)
Follow-up duration (months)
   Total number of patients 122
   Median (range) 57 (5-116)
Vital status
   Alive without disease 99 (81.1)
   Alive with disease 1 (0.8)
   Dead with disease 4 (3.3)
   Dead 18 (14.7)
Recurrence post-endoscopic resection
   No recurrence 103 (84.4)
   Local recurrence 17 (13.9)
   Regional recurrence 2 (1.6)
Time relapsed between surgery and recurrence 
(months)
   Number of patients with local relapse 19
   Median (range) 13 (0-84)Laser surgery of early glottic cancer in elderly
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Discussion
In patients with early glottic cancer, literature data show 
that radiotherapy and conservative surgery provide com-
parable results in terms of local control and overall sur-
vival. Until some years ago, external beam radiotherapy 
with  conventional  fractionation  represented  the  most 
common  form  of  treatment  in  head  and  neck  cancer. 
Compared to surgery, radiotherapy has the advantage to 
be a nonsurgical treatment and to be a simple, non-op-
erator dependent technique, but the radiotherapy-related 
side-effects and the impact of acute and late side-effects 
of such a long treatment in elderly patients’ quality of 
life are still a matter of debate. Jaime Gomez reported 
that the tolerance to radiation in these patients might 
be impaired 12 and Allal et al., underlined how, for this 
reason, treatment interruptions were more common in 
older patients  13. Pignon et al. reported how acute and 
late  toxicities  were  similar  in  elderly  and  in  younger 
patients treated with radiotherapy for a head and neck 
carcinoma, even though older patients had more severe 
functional acute toxicity and late effects may decrease 
quality of life  14. Olmi and co-workers compared out-
comes of radiotherapy with curative intent in patients 
with head and neck carcinoma aged, respectively, less 
than and more than 70 years. They found that no differ-
ences were seen in local control and survival between 
the two age groups  15. Also Colasanto et al. suggested 
that age did not correlate with local relapse rate in pa-
tients with early laryngeal cancer 16. A  nal observation 
regarding radiotherapy in elderly patients may be made: 
radiotherapy failure patients almost always required to-
tal laryngectomy and showed an increase in post-surgi-
cal complications 12-16.
Nowadays, open neck conservative surgery is considered 
an over-treatment for early laryngeal glottic cancer, due 
to low compliance to feeding and phonatory rehabilitation 
in elderly patients, which seriously affects the functional 
outcome of surgery and is frequently associated with an 
increased risk of aspiration pneumonia  17. Nevertheless, 
in older patients the open surgical strategy almost always 
employed is total laryngectomy which is considered an 
over-treatment in early laryngeal glottic cancer.
With today’s ageing population, the quality of residual 
life highlights the importance of the treatment modalities: 
important secondary objectives, such as speaking voice 
and problem-free swallowing, are therefore requested by 
patients. Patient factors such as health and mental status, 
occupation or the desire to move independently, should 
guide  treatment  decisions:  for  ENT  and  oncologists, 
counselling an elderly patient on the optimal management 
of their problem, is sometimes quite a dilemma 18. Medi-
cal conditions are critical to the assessment choice, but 
also recognition of special social economic needs may 
interfere with cancer treatment: the choice of an exclu-
sive radiation treatment in an elderly patient, for example, 
must take into account compliance and the discomfort of 
a treatment time of 6 or more weeks, the distance to the 
radiation centre and dif culties for the family. In addi-
tion, the hidden costs for radiation therapy versus endo-
scopic excision were all greater in terms of total number 
of hours of work missed, total travel time, and total travel 
distance 19.
In conclusion, our experience shows that TLS represents 
a feasible treatment modality in elderly patients with ear-
ly stage glottic cancer providing good results in terms of 
disease-free survival, organ preservation and acute and late 
side-effects. Our group of elderly patients had no clinically 
relevant intra-operative or post-surgical complications and 
resumed normal activities the day after discharge from hos-
pital. In our series, CO2 laser removal of an early glottic 
cancer in elderly patients can be often considered a feasible, 
short hospitalisation and no-risk procedure without com-
promising laryngeal preservation. For patients referred to 
medical centres with expertise for this surgical procedure, 
TLS, therefore, represents a modern treatment that should 
be offered as an alternative to conventional radiotherapy.
Table IV. 10-year (post-resection) survival (n = 122 patients).
Univariate
Events/patients Estimated 10-year survival 95% CI
Overall Survival 22/122 64.9% 47.1-82.7%
Tumour-speciﬁc survival 12/122 84.8%* 76.3-93.2%
Laryngeal tumour-speciﬁc survival 4/122 94.3%* 88.5-100.0%
Relapse-Free Survival 19/122 80.2%† 71.5-88.9%
* Deaths from other causes used as competing events; † 16 deaths occurring in patients with neither local nor regional recurrence, were considered as competing eventsM. Ansarin, et al.
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